Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Tirzepatide (prescribed at different dosages under the brand names Monjauro and Zepbound) was initially intended for the treatment of type 2 diabetes but has been shown to successfully promote weight loss in patients
Niewoehner, J
the amount of time spent in the target blood glucose range, expressed as a % of CGM readings within that range) of 70 to 180 mg/dL (3.9 to 10 mmol/L) at week 12 (assessed using blinded CGM)
Ready meals are expected to lead product demand with a 28.0% share, while high-protein positioning remains the leading nutritional focus at 31.0% of market revenue
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
